| Dr Maria Celia C Gaticales, MD | |
|
116 Summer St, Haverhill, MA 01830-6032 | |
| (978) 373-7010 | |
| Not Available |
| Full Name | Dr Maria Celia C Gaticales |
|---|---|
| Gender | Female |
| Speciality | |
| Experience | Years |
| Location | 116 Summer St, Haverhill, Massachusetts |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205883931 | NPI | - | NPPES |
| 3118878 | Medicaid | MA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 5740 (New Hampshire) | Secondary |
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 38163 (Massachusetts) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Maria Celia C Gaticales, MD 2 Lane Ave, Greenland, NH 03840-2305 Ph: (603) 431-6450 | Dr Maria Celia C Gaticales, MD 116 Summer St, Haverhill, MA 01830-6032 Ph: (978) 373-7010 |
News Archive
Array reported revenue of $5.5 million for the fourth quarter of fiscal 2009, compared to revenue of $6.1 million for the same period in fiscal 2008. Array invested $21.3 million in proprietary research and development for the quarter to advance its seven wholly-owned drugs in clinical development and select discovery programs.
In science, refuting a hypothesis can be as significant as proving one, all the more so in research aimed at elucidating how diseases proceed with a view toward preventing, treating, or curing them. Such a discovery can save scientists from spending precious years of effort exploring a dead end. In a study published in the Proceedings of the National Academy of Sciences, Munich-based researchers refute a widely accepted hypothesis about a causative step in neurodegenerative conditions.
Two leading Medical organisations have called for stricter regulations for sugary drinks marketed for children and young adults.
Preliminary results of a pre-specified subgroup study analysis of patients with diabetes and hypertension demonstrated that the investigational triple combination therapy of olmesartan medoxomil / amlodipine / hydrochlorothiazide (40/10/25 mg) resulted in a statistically significant greater Least Squares mean reduction in blood pressure from baseline at week 12 (37.9/22.0 mm Hg versus 26.4-28.0/14.7-17.6 mm Hg, P less than or equal to 0.0013) as compared to corresponding dual combination therapy [olmesartan medoxomil (40 mg) / amlodipine (10 mg); olmesartan medoxomil (40 mg) / hydrochlorothiazide (25 mg); or amlodipine (10 mg) and hydrochlorothiazide (25 mg)].
› Verified 2 days ago
Dr. Kai Spring Hayes, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 140 Lincoln Ave, Adult Behavioral Unit, Haverhill, MA 01830 Phone: 978-521-8339 Fax: 978-521-3658 | |
Chitra Malur, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 62 Brown St, Suite 507, Haverhill, MA 01830 Phone: 617-562-5628 | |
Dr. Helen N Walsh, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 60 Merrimack St, Haverhill, MA 01830 Phone: 978-373-1126 Fax: 978-373-6363 | |
Ping Cui, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 288 Groveland St, Suite C2, Haverhill, MA 01830 Phone: 978-521-8810 Fax: 978-521-8811 | |
Katherine G Ruiz-mellott, M.D.,MPH Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 76 Summer Street, Whittier Pavilion, Haverhill, MA 01830 Phone: 978-556-6229 |